- Home
- / Harpoon Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Harpoon Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$23
2024-03-11
Market Capitalization
$492.3 M
2024-03-11
Revenue
$31.9 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | 708.0K | 4.8M | 5.8M | 17.4M | 23.7M | 31.9M | |
| General and administrative expense | 3.4M | 3.6M | 6.1M | 22.4M | 16.2M | 18.3M | 18.8M |
| Operating expense total | 11.1M | 17.2M | 32.5M | 64.0M | 68.8M | 100.2M | |
| EBIT | (11.1M) | (16.5M) | (27.7M) | (58.2M) | (51.3M) | (116.8M) | (68.3M) |
| EBIT margin, % | -2334.5% | -583.7% | -1007.5% | -294.3% | -214.1% | ||
| Interest income | 395.0K | 2.7M | 1.4M | 240.0K | 776.0K | ||
| Interest expense | 261.0K | 285.0K | |||||
| Net Income | (11.4M) | (16.8M) | (27.4M) | (55.6M) | (49.9M) | (116.7M) | (67.7M) |
| EPS | (2.0) |